Skip to content

comparison of escitalopram and venlafaxine in first episode depression

Effect of escitalopram and venlafaxine on cognition and quality of life in patients with treatment naive first episode of non psychotic unipolar depression - CEVD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/11/010347
Enrollment
60
Registered
2017-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- first episode unipolar depression

Interventions

Intervention1: venlafaxine: selective serotonin and norepinephrine reuptake inhibitor Control Intervention1: escitalopram: selective serotonin reuptake inhibitor

Sponsors

GMCH chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of unipolar depression as per ICD-10. 2. Treatment naive patients. 3. Patients in the age group of 18-55 years. 4. Patients willing to participate in study. 5. Patients with reliable informant

Exclusion criteria

Exclusion criteria: 1. Patients of bipolar depression and recurrent depressive disorder. 2. Patients with Severe depressive episode with psychotic symptoms. 3. Patients with co-morbid substance related disorders except nicotine & caffeine. 4. Patients with subnormal intelligence. 5. Pregnant and lactating patients. 6. Any history of medical, surgical neurological complication/cognitive impairment or any other condition in which these medications are contraindicated. 7. Actively Suicidal patients.

Design outcomes

Primary

MeasureTime frame
response with the minimum therapeutic dosage of the moleculeTimepoint: 2 weeks

Secondary

MeasureTime frame
assessment of response side effects and effect on cognition and quality of life with both the moleculesTimepoint: 3 months

Countries

India

Contacts

Public Contactdr Ajeet sidana

Governement medical college and hospital sector 32 Chandigarh

ajeetsidana@hotmail.com9646121614

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026